NAD Depletion as a Cancer Strategy

Dr. Michael Greger reviews attempts to use NAD-depleting drugs in cancer and associated retinal toxicity risks.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!